Deep-Insight

Deep-Insight is a company that specializes in enhancing B2B customer experience through its innovative platform focused on data analytics, customer relationship management (CRM), and employee engagement. It offers a proprietary technology-based toolset that analyzes data to improve customer and employee retention. By leveraging this platform, Deep-Insight enables businesses to gain valuable insights into the perceptions and experiences of their corporate clients and channel partners. This approach helps organizations understand and strengthen their relationships with both customers and employees, ultimately enhancing overall satisfaction and loyalty.
https://crunchbase.com/organization/***
https://linkedin.com/company/***

John O'Connor

CEO

1 past transactions

Exsilio Therapeutics

Series A in 2024
Exsilio Therapeutics develops tools that use naturally occurring genetic elements to insert therapeutic genes into cells via RNA intermediates. The company combines computational modeling with laboratory experiments to design elements that target safe harbor sites in disease‑relevant cells, enabling precise and stable gene integration. Its peer, Averna Therapeutics, also employs similar genetic elements but focuses on delivering medicines in lipid nanoparticles to treat a broad range of diseases, including genetic disorders, cancer, and autoimmune conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.